Levothyroxine, commercially known as Synthroid ... “For a study to have strength, you need it to be done on thousands and thousands of people,” Safai said. “This study showed that there ...

"A risk-benefit assessment should be conducted, weighing the strength of the indications for treatment against the potential adverse effects of levothyroxine in this population," she said.